Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;53(7):479-485.
doi: 10.1080/23744235.2021.1905174. Epub 2021 Apr 13.

Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature

Anna Teresa Roberts  1 , Fiorella Piani  1 , Benedetta Longo  2 , Roberto Andreini  2 , Simone Meini  2
Affiliations

Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature

Anna Teresa Roberts et al. Infect Dis (Lond). 2021 Jul.

Abstract

Introduction: The duration of immunity after infection from SARS-CoV-2 conferring protection from subsequent COVID-19 episodes is not yet fully understood. We reviewed the literature for cases of documented reinfection.

Materials and methods: A comprehensive computerized search in PubMed, through 15 December 2020, using the following terms in combination: COVID-19, SARS-CoV-2, reinfection, reactivation, recurrence. To exclude cases due to prolonged viral shedding or protracted infection, only cases occurring at least 12 weeks apart or confirmed as being sustained by genetically different viruses by viral genome analysis were included.

Results: We identified 23 cases globally, for which viral genome analysis was performed in 10 cases and serology in 19 cases. The mean interval between the two episodes was 15 weeks. Mean age of cases was 44.5 years, and 10 (43.5%) were women. In 17/23 cases, no comorbidity was observed. In 10 cases, the first episode was more severe than the ensuing episode, whereas in seven cases the ensuing episode was more severe. In four cases, there was no difference in severity and in two cases both episodes were asymptomatic.

Conclusions: From this sample of 23 cases, a clear pattern of the second episode being less or more severe did not emerge. A better understanding of immunity to SARS-CoV-2, necessary to assess the probability of a second infection and the durability of protection conferred by vaccination, is warranted.

Keywords: COVID-19; SARS-CoV-2; immunity; reactivation; recurrence; reinfection; serology.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Comment in

References

    1. Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26(11):1691–1693. - PubMed
    1. Tan Y, Liu F, Xu X, et al. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med. 2020;1–6. - PMC - PubMed
    1. Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. 2020;81(5):816–846. - PMC - PubMed
    1. Tomassini S, Kotecha D, Bird PW, et al. Setting the criteria for SARS-CoV-2 reinfection – six possible cases. J Infect. 2020;82(2):282–327. - PMC - PubMed
    1. Arafkas M, Khosrawipour T, Kocbach P, et al. Current meta-analysis does not support the possibility of COVID-19 reinfections. J Med Virol. 2021;93(3):1599–1604. - PubMed

LinkOut - more resources